Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG) and LivaNova (LIVN)
TipRanksApr 10 02:51 ET
Piper Sandler Keeps Their Buy Rating on LivaNova (LIVN)
TipRanksApr 2 06:55 ET
LivaNova Analyst Ratings
BenzingaMar 27 13:13 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: LivaNova (LIVN), Vor Biopharma (VOR) and Neurogene (NGNE)
TipRanksMar 21 05:21 ET
LivaNova Analyst Ratings
BenzingaMar 20 12:12 ET
LivaNova's Aura6000 Poised for Success in OSA Market: A Buy Rating Overview
TipRanksMar 20 11:55 ET
LivaNova Analyst Ratings
BenzingaFeb 27 09:38 ET
LivaNova Analyst Ratings
BenzingaFeb 26 07:22 ET
Baird Adjusts LivaNova's Price Target to $62 From $56, Keeps Neutral Rating
MT NewswiresFeb 22 11:47 ET
LivaNova Analyst Ratings
BenzingaFeb 22 11:07 ET
LivaNova Analyst Ratings
BenzingaFeb 21 11:21 ET
LivaNova Analyst Ratings
BenzingaFeb 20 07:39 ET
LivaNova (LIVN) Receives a Buy From Stifel Nicolaus
TipRanksNov 21, 2023 07:45 ET
LivaNova Analyst Ratings
BenzingaNov 17, 2023 05:53 ET
Analysts Conflicted on These Healthcare Names: LivaNova (LIVN), Immutep (IMMP) and Nurix Therapeutics (NRIX)
TipRanksNov 6, 2023 01:31 ET
LivaNova Analyst Ratings
BenzingaOct 23, 2023 06:53 ET
HSBC Initiates Coverage On LivaNova With Hold Rating, Announces Price Target of $52
BenzingaSep 6, 2023 05:32 ET
LivaNova Analyst Ratings
BenzingaSep 6, 2023 05:31 ET
Stifel Nicolaus Sticks to Their Buy Rating for LivaNova (LIVN)
TipRanksJul 31, 2023 22:06 ET
Barclays Maintains Equal-Weight on LivaNova, Raises Price Target to $57
BenzingaJul 27, 2023 08:06 ET
No Data
No Data